TNS, Inc. (TNS) Tops Q3 EPS by 4c; Boosts FY12 Outlook
Tweet
Share
E-mailGet Alerts TNS Hot Sheet
Price: $21.00 --0%
Financial Fact:
Interest expense: -3.19M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Interest expense: -3.19M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
TNS, Inc. (NYSE: TNS) reported Q3 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $137.2 million versus the consensus estimate of $133.3 million.
TNS, Inc. sees FY2012 EPS of $2.24-2.32, versus prior guidance of $2.17-2.32 and the consensus of $2.21. TNS, Inc. sees FY2012 revenue of $545-550 million, versus prior guidance of $540-550 million and the consensus of $542.70 million.
For earnings history and earnings-related data on TNS, Inc. (TNS) click here.
TNS, Inc. sees FY2012 EPS of $2.24-2.32, versus prior guidance of $2.17-2.32 and the consensus of $2.21. TNS, Inc. sees FY2012 revenue of $545-550 million, versus prior guidance of $540-550 million and the consensus of $542.70 million.
For earnings history and earnings-related data on TNS, Inc. (TNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
- BK Technologies (BKTI) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
